Skip to search formSkip to main contentSkip to account menu

Peripheral T-Cell Lymphoma

Known as: Lymphoma, Peripheral T-Cell, T-Cell Lymphoma, Peripheral, Lymphomas, Peripheral T-Cell 
A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad… 
National Institutes of Health

Related topics

Related topics

27 relations
Atypical lymphocyteHematopoietic and Lymphoid CellHematopoietic and Lymphoid TissueHemophagocytic Syndrome

Broader (1)

T-Cell Lymphoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
Peripheral T-cell lymphomas (PTCLs) are rare lymphomas with mostly poor outcome with current treatment. The addition of etoposide… 
Highly Cited
2012
Highly Cited
2012
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
Inactivating mutations of the Ten-Eleven Translocation 2 (TET2) gene were first identified in myeloid malignancies and more… 
Review
2009
Review
2009
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.
  • E. Jaffe
  • Hematology. American Society of Hematology…
  • 2009
  • Corpus ID: 5910575
The 4(th) edition of the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues published in 2008 builds upon the… 
Highly Cited
2008
Highly Cited
2008
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
PURPOSE Aggressive T-cell lymphomas (ATCLs) represent 10% to 15% of non-Hodgkin's lymphomas (NHLs) in adults. ATCLs show a worse… 
Highly Cited
2007
Highly Cited
2007
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial…
To evaluate in a prospective multicenter trial the feasibility and clinical efficacy of the combination of alemtuzumab (Campath… 
Highly Cited
2006
Highly Cited
2006
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.
PURPOSE Although peripheral T-cell lymphoma, unspecified (PTCL/U), is the most common T-cell tumor in Western countries, no study… 
Highly Cited
2004
Highly Cited
2004
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.
PURPOSE Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of malignancies characterized by a poor prognosis. We… 
Review
2004
Review
2004
Preparation of metal nanoparticles in water-in-oil (w/o) microemulsions.
Review
2002
Review
2002
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.
BACKGROUND Peripheral T-cell lymphoma (PTCL) is rare in most parts of the world. Therefore, we have evaluated the 96 cases of… 
Highly Cited
1996
Highly Cited
1996
Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology.
A workshop jointly sponsored by the University of Hong Kong and the Society for Hematopathology explored the definition… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)